Maintaining and reprogramming genomic androgen receptor activity in prostate cancer
- PMID: 24561445
- DOI: 10.1038/nrc3678
Maintaining and reprogramming genomic androgen receptor activity in prostate cancer
Erratum in
- Nat Rev Cancer. 2014 May;14(5). doi: 10.1038/nrc3722
Abstract
Prostate cancer treatment is dominated by strategies to control androgen receptor (AR) activity. AR has an impact on prostate cancer development through the regulation of not only transcription networks but also genomic stability and DNA repair, as manifest in the emergence of gene fusions. Whole-genome maps of AR binding sites and transcript profiling have shown changes in the recruitment and regulatory effect of AR on transcription as prostate cancer progresses. Defining other factors that are involved in this reprogramming of AR function gives various opportunities for cancer detection and therapeutic intervention.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials